Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Hao Jiang
DNA biology and leukemia
Alec Zhang
myeloma, immunotherapy
Mala Shanmugam
myeloma
Stephen Gottschalk
pediatric leukemia and CAR-T
Omar Abdel-Wahab
Hairy cell leukemia
Caner Saygin
T-ALL
Jaroslaw Maciejewski
bone marrow failure
Daniel Herranz
T-ALL
Matthew Frank
Lymphoma CART therapy
James Rubenstein
Lymphoma of the Central Nervous System
Michael Green
lymphoma biology
Catherine Bollard
pediatric blood cancers and immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Constellation Pharmaceuticals
myeloproliferative neoplasms
Nicolas Nassar
pediatric leukemia
Gianpietro Dotti
CAR T and AML
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Luca Busino
DLBCL
William Matsui
Myeloma
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Eugenio Morelli
Myeloma
Nicoletta Cieri
AML and transplantation
Susan Schwab
cancer immunology
Catherine Diefenbach
DLBCL immunology
Jianguo Tao
Mantle Cell Lymphoma
Suman Paul
T cell cancers and immunotherapy
Fahmin Basher
transplant and GvHD
Sahand Hormoz
MPN
Gaurav Goyal
Erdheim-Chester Disease
Soheil Meshinchi
pediatric AML
Markus Muschen
leukemia and lymphoma biology
Alfred Garfall
myeloma immunotherapy
Tomasz Skorski
myeloproliferative neoplasms, AML
Sarah Tasian
pediatric leukemias
Jianhua Yu
myeloma immunotherapy
Dane Vassiliadis
blood cancer biology
Stephen Nimer
myeloid cancer biology
Christopher Booth
BPDCN
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Sham Mailankody
Myeloma immunotherapy clinical trials
Martin Dreyling
Mantle Cell Lymphoma
Enrico Tiacci
Hairy cell leukemia
Anushree Vichare
Equity in Access
Jessica Stewart
Epstein-barr virus and lymphomas
Simona Colla
Myeloma biology
Justine Kahn
pediatric leukemia and lymphoma
Jean Koff
Disparities in DLBCL
Christine Zhang
AML
Jalpa Doshi
Equity in Access
Jonathan Licht
DNA biology, myeloma
Randall Davis
CLL
Mark Hamilton
DLBCL and CAR-T
Arash Alizadeh
blood cancer biology and diagnosis
Marc Seifert
Hairy cell leukemia
Yoke Seng Lee
AML
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Christopher Flowers
clinical trial access
Steven Horwitz
T-cell lymphomas
Reina Takeda
AML
Margaret Shipp
lymphoma biology
Jun Qi
Myeloma
Jing Fu
myeloma
Keisuke Ito
blood cancer stem cells and MDS metabolism
Courtney Jones
AML metabolism
Paul Beavis
immunotherapy in myeloma
Kerry Rogers
CLL
Adi Nagler
Bronchiolitis obliterans after transplant
Elliot Stieglitz
CMML
Lindsey Montefiori
pediatric leukemia
Carl June
CAR T immunotherapy
Nataly Cruz-Rodriguez
T-ALL and metabolism
Caroline Arber
myeloma CAR-T
Jonas Jutzi
myeloproliferative neoplasms
Nirav Shah
CAR-T for lymphoma
Alexey Danilov
lymphoma
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Daniel Starczynowski
MDS and AML
Jenny Wang
AML
ImCheck Therapeutics
immunotherapy, AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Stephen Oh
myeloproliferative neoplasms
Riccardo Dalla-Favera
lymphoma (DLBCL)
Megan McNerney
AML/MDS
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Liran Shlush
pre-leukemia
Brian Dalton
DNA mutations and myeloid cancers
Kimberly Stegmaier
childhood blood cancers
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Inhye Ahn
CLL
Jake Shortt
precision therapy for aggressive lymphomas
Mendel Goldfinger
MDS/AML trials for the elderly
Michael Kharas
leukemia
Robert Orlowski
(Smoldering) Multiple Myeloma
Neha Mehta-Shah
T-cell lymphoma
Christian Steidl
B-cell lymphomas
Nizar Bahlis
Myeloma immunotherapy
Alieen Rowan
Adult T cell leukemia/lymphoma
Courtney DiNardo
clinical trials, AML
Suzanne Lentzsch
Myeloma
Liling Wan
AML
Srividya Swaminathan
pediatric, immunotherapy
Eric Padron
CMML
Ryan Wilcox
T-cell lymphoma
Matteo Bellone
Smoldering multiple myeloma
Qing Yi
Novel CAR-T
Hong Wen
AML
Paolo Caimi
CAR-T clinical trial for CLL
Brian Walker
smoldering myeloma, MGUS
Jonathon Cohen
lymphoma clinical trial access in Georgia
Britta Will
Leukemia and pre-leukemia
Tyler Parsons
MPN and AML
Jaehyuk Choi
T-cell lymphoma
Anouchka Laurent
T-cell lymphoma
John Crispino
MPNs, myelofibrosis
Jennifer Woyach
CLL trials
Kirk Schultz
pediatric transplantation
George Vassiliou
Leukemia Prevention
Thomas Kipps
Hairy Cell Leukemia
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Mark Murakami
follicular lymphoma
Steven Park
follicular lymphoma
Jayna Mistry
aging and leukemias
Xu Ji
Equity in Access
BioInvent International
immunotherapy, indolent NHL, CTCL
Venkata Lokesh Battula
immunotherapy and AML
Richard Lock
T-ALL
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Coleman Lindsley
AML/MDS
Sisi Chen
leukemia
Carl Allen
pediatric blood cancers
Gareth Morgan
smoldering myeloma, MGUS
Enterome
vaccine, FL, MZL
Michael Keller
COVID-19, immunotherapy
Jeffrey Magee
pediatric AML
Raymond Mailhot
Equity in Access
Michael Savona
MDS and leukemia
Noemí Puig Morón
Myeloma
Caron Jacobson
lymphoma and immunotherapy
Kathleen Sakamoto
pediatric AML
Nicola Vannini
Aging and CAR-T success
Thomas LeBlanc
palliative care
Helen Parsons
Equity in Access
Ronald Levy
immunotherapies, COVID-19
Michaela Reagan
Multiple Myeloma
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Meng Li
Equity in Access
Affimed
immunotherapy, HL, PTCL
Catherine Smith
leukemia
Tanya Siddiqi
clinical trial access
Carma Bylund
Equity in Access
Wendy Stock
T-cell ALL
Yibin Yang
Lymphoma
Solu Therapeutics
immunotherapy, CMML
Christian Marinaccio
MLL leukemias
Sergei Doulatov
Leukemias
Teresa Palomero
Peripheral T-cell Lymphoma
Taishi Yonezawa
AML
Jeetayu Biswas
splicing in myeloid diseases
Anthony Letai
improving CAR-T
Dimericon Therapeutics
dimericons, blood cancer
Thomas Koehnke
leukemia
Madhav Dhodapkar
multiple myeloma immunotherapy
Shazia Nakhoda
Equity in Access
Philippe Armand
follicular lymphoma
Siegfried Janz
Myeloma immunotherapy
Bing Carter
p53 mutant AML
Qingyu Luo
BPDCN
Robert Soiffer
transplantation
Alex Kentsis
pediatric leukemias
Cailin Collins
Leukemia and pre-leukemia
Amit Verma
AML/MDS
Timothy Graubert
AML and MDS biology
Dan Landau
cancer evolution biology
Wendy Béguelin
follicular lymphoma
Siddhartha Jaiswal
preleukemia
Eirini Papapetrou
blood cancer stem cells
Huda Salman
CMML
Mark Dawson
B-ALL and CAR-T resistance
Rgenta Therapeutics
RNA-targeting, blood cancer
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Ravi Bhatia
transplantation
Kasey Leger
pediatric blood cancers
Ricky Johnstone
lymphoma and myeloma
Julia Maxson
AML
Jolanta Grembecka
leukemia therapeutics
Peter Klein
MDS
Bingyi Chen
AML immunotherapy
Rong Lu
preleukemia, leukemia
Fenghuang Zhan
Myeloma and bone disease
Lawrence Boise
CART and myeloma
Daniel Pollyea
AML
Rajni Kumari
AML
Daniel Lucas
bone marrow and leukemia biology
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Yan Liu
MDS
Ravindra Majeti
preleukemia, AML
Frederike Kramer
MPNs
Alison Moskowitz
lymphoma therapeutics
Saar Gill
AML immunotherapy
Craig Jordan
AML
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Julia Paczkowska
immunobiology of Hodgkin's disease
Jeremy Baeten
AML
Joachim Yahalom
Lymphoma
Andrew Lane
BPDCN
Marco Ruella
Immunotherapy for T-cell lymphoma
Jennifer Trowbridge
aging and leukemia
F. Lennie Wong
Equity in Access
Faron Pharmaceuticals
immunotherapy, MDS
Trent Hall
MDS
Daniel Thomas
Myelofibrosis
Nitin Jain
CLL
Kura Oncology
MLL leukemia, AML
John DiPersio
trispecific antibody for AML and MDS
Catriona Jamieson
cancer stem cell biology
Shannon Maude
Immunotherapy for ALL
Sam Butterworth
CMML
Yiman Liu
Epigenetics and leukemia
Yubin Zhou
peripheral T cell lymphoma
Ruben Carrasco
Myeloma
Christopher Porter
Leukemia, lymphoma
Roberta Zappasodi
lymphoma, immunotherapy
Pietro Genovese
transplant and AML
Lakshmi Nayak
brain tumors in lymphoma
Takeshi Sugio
T-cell lymphoma
Amin Sobh
Myeloma biology
Jing Yang
Myeloma
Rizwan Romee
Immunotherapy
Steven Treon
Lymphomas and Waldenstrom's
Leandro Cerchietti
DLBCL
Michael Wang
Mantle Cell Lymphoma
Bailee Kain
AML and African ancestry
Oreofe Odejide
Equity in Access
Lucy Godley
preleukemia
Ana Vujovic
AML
Ari Melnick
epigenetics and lymphoma
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Eric Pietras
AML
Sheng Li
Aging and AML
Tycel Phillips
Mantle Cell Lymphoma
Daisuke Nakada
preleukemia, leukemia
Maximilian Stahl
AML immunotherapy
Sriram Sundaravel
AML stem cells
Armin Rashidi
gut bacteria and transplant success
Logan Spector
childhood leukemia epidimiology
Areej El-Jawahri
transplant survivorship
Lori Muffly
Equity in Access
Marina Konopleva
MDS/AML metabolism
Grant Challen
preleukemia, leukemia
H. Irene Su
Equity in Access
Piers Patten
COVID-19
Tak Mak
Immunotherapy
Paolo Strati
Non-Hodgkin Lymphoma
Bruno Paiva
smoldering myeloma
Sigurður Kristinsson
Smoldering myeloma
John Leonard
lymphoma research
Koichi Takahashi
AML/MDS
Pooja Khandelwal
bone marrow transplantation
Manyi Wei
acute megakaryoblastic leukemia
Ann-Kathrin Eisfeld
Racial diversity in AML
Lev Kats
myeloma and epigenetics
Grzegorz Nowakowski
Clinical trial access
Adam Olszewski
Follicular and marginal zone lymphoma
Frederick Locke
lymphoma and immunotherapy
Adam de Smith
pediatric ALL and Down Syndrome
Roland Walter
Antibody-based AML therapies
Stacie Dusetzina
Equity in Access
Peter Croucher
Multiple Myeloma